HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.

@article{Palefsky2011HPVVA,
  title={HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.},
  author={J. Palefsky and A. Giuliano and S. Goldstone and E. Moreira and C. Aranda and H. Jessen and R. Hillman and D. Ferris and F. Coutl{\'e}e and M. Stoler and J. B. Marshall and D. Radley and S. Vuocolo and R. Haupt and D. Guris and E. Garner},
  journal={The New England journal of medicine},
  year={2011},
  volume={365 17},
  pages={
          1576-85
        }
}
BACKGROUND The rate of anal cancer is increasing among both women and men, particularly men who have sex with men. Caused by infection with human papillomavirus (HPV), primarily HPV type 16 or 18, anal cancer is preceded by high-grade anal intraepithelial neoplasia (grade 2 or 3). We studied the safety and efficacy of quadrivalent HPV vaccine (qHPV) against anal intraepithelial neoplasia associated with HPV-6, 11, 16, or 18 infection in men who have sex with men. METHODS In a substudy of a… Expand
HPV vaccine against anal intraepithelial neoplasia.
Prophylactic HPV vaccination and anal cancer
High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men.
Quadrivalent human papillomavirus vaccine: updated recommendations for males.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.
Human papillomavirus-related disease in people with HIV
Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
...
1
2
3
...